Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 24;17(10):1257.
doi: 10.3390/ph17101257.

Antioxidant and Pro-Oxidant Properties of Selected Clinically Applied Antibiotics: Therapeutic Insights

Tibor Maliar  1 , Marcela Blažková  2   3 , Jaroslav Polák  4 , Mária Maliarová  1 , Eva Ürgeová  2 , Jana Viskupičová  5
Affiliations

Antioxidant and Pro-Oxidant Properties of Selected Clinically Applied Antibiotics: Therapeutic Insights

Tibor Maliar et al. Pharmaceuticals (Basel). .

Abstract

Background: The balance between antioxidants and pro-oxidants plays a significant role in the context of oxidative stress, influenced by both physiological and non-physiological factors.

Objectives: In this study, 18 prescribed antibiotics (including doxycycline hydrochloride, tigecycline, rifampicin, tebipenem, cefuroxime, cefixime, potassium clavulanate, colistin, ampicillin, amoxicillin, amikacin, nalidixic acid, azithromycin, pipemidic acid trihydrate, pivmecillinam, aztreonam, fosfomycin sodium, and ciprofloxacin) were subjected to simultaneous determination of antioxidant and pro-oxidant potential to assess if pro-oxidant activity is a dominant co-mechanism of antibacterial activity or if any antibiotic exhibits a balanced effect.

Methods: This study presents a recently developed approach for the simultaneous assessment of antioxidant and pro-oxidant potential on a single microplate in situ, applied to prescribed antibiotics.

Results: Ten antibiotics from eighteen showed lower antioxidant or pro-oxidant potential, while five exhibited only mild potential with DPPH50 values over 0.5 mM. The pro-oxidant antioxidant balance index (PABI) was also calculated to determine whether antioxidant or pro-oxidant activity was dominant for each antibiotic. Surprisingly, three antibiotics-doxycycline hydrochloride, tigecycline, and rifampicin-showed significant measures of both antioxidant and pro-oxidant activities. Especially notable was tebipenem, a broad-spectrum, orally administered carbapenem, showed a positive PABI index ratio, indicating a dominant antioxidant over pro-oxidant effect.

Conclusions: These findings could be significant for both therapy, where the antibacterial effect is enhanced by radical scavenging activity, and biotechnology, where substantial pro-oxidant activity might limit microbial viability in cultures and consequently affect yield.

Keywords: antibiotics; antioxidant activity; oxidative stress; pro-oxidant activity.

PubMed Disclaimer

Conflict of interest statement

Author Jaroslav Polák was employed by the company Helgeheim, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Structure of the antibiotic doxycycline quaternary cation after MM-QM optimization. Oxygen atoms are labeled with their atom number and type, and partial charges are provided in the accompanying table.
Figure 2
Figure 2
Target prediction analysis of possible human targets for the tetracycline doxycycline hydrochloride.
See this image and copyright information in PMC

References

    1. WHO Collaborating Centre for Drug Statistics Methodology. Purpose of the ATC/DDD System. Archived from the Original on 14 January 2010. [(accessed on 6 July 2021)]. Available online: https://atcddd.fhi.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/
    1. Reffat N., Schwei R.J., Griffin M., Pop-Vicas A., Schulz L.T., Michael S., Pulia M.S. A Scoping Review of Bacterial Resistance Among Inpatients Amidst the COVID-19 Pandemic. J. Glob. Antimicrob. Resist. 2024;38:49–65. doi: 10.1016/j.jgar.2024.05.010. - DOI - PMC - PubMed
    1. De la Fuente-Nunez C., Cesaro A., Hancock R.E.W. Antibiotic failure: Beyond antimicrobial resistance. Drug Resist. Updat. 2023;71:101012. doi: 10.1016/j.drup.2023.101012. - DOI - PubMed
    1. Prakash C., Long J., Edelkamp P., Knafl M., Ahmed S., Khawaja F., Nastoupil L.J., Manzano J.G., Mulanovich V., Prabhakaran S., et al. Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections. Blood. 2022;140:10907–10908. doi: 10.1182/blood-2022-169853. - DOI
    1. Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.-P.R., Nick Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020;26:1622–1629. doi: 10.1016/j.cmi.2020.07.016. - DOI - PMC - PubMed

LinkOut - more resources